1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Vital Signs The Analyst%s Perspective - August 2015 Issue 

Vital Signs The Analyst%s Perspective - August 2015 Issue 

  • September 2015
  • -
  • Frost & Sullivan
  • -
  • 6 pages

Vital Signs The Analyst's Perspective - August 2015 Issue

This issue of Vital Signs discusses the FDA's clearnace of the first 3-D printed prescription drug, Illumina's formation of consumer genomics company Helix, Response Genetics' acquisition of Cancer Genetics, and Roche's acquisition of GeneWEAVE.

Table Of Contents

Vital Signs The Analyst%s Perspective - August 2015 Issue 
LIFE SCIENCES
FDA Clears First 3D Printed Prescription Drug 2
Illumina, Inc and Investors Form Consumer Genomics Company Helix 3
Response Genetics Enters Into Asset Purchase Agreement with Cancer Genetics 4
Roche's Acquisition Spree Continues with its Purchase of GeneWEAVE
for $425 Million 5

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global Companion Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts

Global Companion Diagnostics Partnering 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Companion Diagnostics Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the ...

Oncology drug report - Adcetris - brentuximab vedotin - 2011-2015 analysis; 2016-2021 expectations

Oncology drug report - Adcetris - brentuximab vedotin - 2011-2015 analysis; 2016-2021 expectations

  • $ 500
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Adcetris: 2011-2015 analysis; 2016-2021 expectations” is a comprehensive report on the first and only approved drug of Seattle Genetics called Adcetris, which is also the first drug approved by the ...

Meat Substitutes Market by Type, Source, Category, and Region - Global Forecast to 2022

Meat Substitutes Market by Type, Source, Category, and Region - Global Forecast to 2022

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

“The meat substitutes market is projected to grow at a CAGR of 6.6%” The meat substitutes market is projected to reach USD 5.96 billion by 2022, at a CAGR of 6.6% from 2016. The market is driven by ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.